ECSP16024805A - Nuevo compuesto para el tratamiento de hipoglicemia severa - Google Patents

Nuevo compuesto para el tratamiento de hipoglicemia severa

Info

Publication number
ECSP16024805A
ECSP16024805A ECIEPI201624805A ECPI201624805A ECSP16024805A EC SP16024805 A ECSP16024805 A EC SP16024805A EC IEPI201624805 A ECIEPI201624805 A EC IEPI201624805A EC PI201624805 A ECPI201624805 A EC PI201624805A EC SP16024805 A ECSP16024805 A EC SP16024805A
Authority
EC
Ecuador
Prior art keywords
treatment
new compound
severe hypoglycemia
hypoglycemia
severe
Prior art date
Application number
ECIEPI201624805A
Other languages
English (en)
Inventor
Robert Chadwick Cummins
Jorge Alsina-Fernandez
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=52278803&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ECSP16024805(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of ECSP16024805A publication Critical patent/ECSP16024805A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/605—Glucagons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Emergency Medicine (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Steroid Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Removal Of Specific Substances (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

La presente invención se refiere a un nuevo compuesto útil en el tratamiento de hipoglicemia.
ECIEPI201624805A 2013-12-18 2016-06-16 Nuevo compuesto para el tratamiento de hipoglicemia severa ECSP16024805A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201361917658P 2013-12-18 2013-12-18

Publications (1)

Publication Number Publication Date
ECSP16024805A true ECSP16024805A (es) 2017-02-24

Family

ID=52278803

Family Applications (1)

Application Number Title Priority Date Filing Date
ECIEPI201624805A ECSP16024805A (es) 2013-12-18 2016-06-16 Nuevo compuesto para el tratamiento de hipoglicemia severa

Country Status (26)

Country Link
US (1) US9688736B2 (es)
EP (1) EP3083669A1 (es)
JP (1) JP2017503782A (es)
KR (1) KR20160077215A (es)
CN (1) CN105793282A (es)
AP (1) AP2016009268A0 (es)
AR (1) AR098616A1 (es)
AU (1) AU2014366427B2 (es)
BR (1) BR112016012505A2 (es)
CA (1) CA2928987A1 (es)
CL (1) CL2016001473A1 (es)
CR (1) CR20160223A (es)
DO (1) DOP2016000128A (es)
EA (1) EA201691036A1 (es)
EC (1) ECSP16024805A (es)
HK (1) HK1224303A1 (es)
IL (1) IL245399A0 (es)
MA (1) MA39108A1 (es)
MX (1) MX2016007984A (es)
NZ (1) NZ719451A (es)
PE (1) PE20160787A1 (es)
PH (1) PH12016501184A1 (es)
SG (1) SG11201604232TA (es)
TN (1) TN2016000180A1 (es)
TW (1) TW201609129A (es)
WO (1) WO2015094878A1 (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI622596B (zh) * 2015-10-26 2018-05-01 美國禮來大藥廠 升糖素受體促效劑
WO2019140024A1 (en) 2018-01-12 2019-07-18 Eli Lilly And Company Combination therapy
EP3921336B1 (en) 2019-02-05 2023-03-01 Eli Lilly And Company Glucagon analog agonists and methods of using the same

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101578102B (zh) * 2007-01-05 2013-07-17 印第安纳大学研究及科技有限公司 在生理性pH缓冲液中显示增强的溶解性的胰高血糖素类似物
US20110065633A1 (en) 2008-01-30 2011-03-17 Indiana University Research And Technology Corporation Ester-based peptide prodrugs
CA2728284C (en) 2008-06-17 2019-09-10 Richard D. Dimarchi Glucagon/glp-1 receptor co-agonists
TWI541023B (zh) * 2008-06-17 2016-07-11 印第安納大學科技研究公司 在生理ｐｈ緩衝液中呈現增強之溶解度及穩定性之升糖激素類似物
EP2376097A4 (en) 2008-12-19 2012-10-03 Univ Indiana Res & Tech Corp PEPTIDE PRODRUGS OF AMIDE-BASED GLUCAGON SUPERFAMILY
JP6054742B2 (ja) 2009-07-13 2016-12-27 ジーランド ファーマ アクティーゼルスカブ アシル化グルカゴン類似体
WO2011088837A1 (en) 2010-01-20 2011-07-28 Zealand Pharma A/S Treatment of cardiac conditions
KR20120123443A (ko) 2010-01-27 2012-11-08 인디애나 유니버시티 리서치 앤드 테크놀로지 코퍼레이션 대사 장애 및 비만 치료용 글루카곤 길항제-ｇｉｐ 항진제 콘쥬게이트
WO2011117417A1 (en) * 2010-03-26 2011-09-29 Novo Nordisk A/S Novel glucagon analogues
KR20130018410A (ko) * 2010-03-26 2013-02-21 노보 노르디스크 에이/에스 새로운 글루카곤 유사체
RU2012153753A (ru) 2010-05-13 2014-06-20 Индиана Юниверсити Рисерч Энд Текнолоджи Корпорейшн Пептиды глюкагонового суперсемейства, обладающие активностью в отношении сопряженных с g-белком рецепторов
ES2661228T3 (es) 2010-05-13 2018-03-28 Indiana University Research And Technology Corporation Péptidos de la superfamilia de glucagón que muestran actividad de receptor nuclear de hormona
US8778872B2 (en) 2010-06-24 2014-07-15 Indiana University Research And Technology Corporation Amide based glucagon superfamily peptide prodrugs
CA2802897A1 (en) 2010-06-24 2011-12-29 Zealand Pharma A/S Glucagon analogues
WO2011163473A1 (en) 2010-06-25 2011-12-29 Indiana University Research And Technology Corporation Glucagon analogs exhibiting enhanced solubility and stability in physiological ph buffers
RU2013133803A (ru) 2010-12-22 2015-01-27 Маркадиа Байотек, Инк. Способы лечения метаболических нарушений и ожирения при помощи пептидов на основе глюкагона, активных по отношению к рецепторам гип и гпп
EA201390796A1 (ru) 2011-01-20 2014-07-30 Зилэнд Фарма А/С Применение ацилированного аналога глюкагона
RU2013145013A (ru) * 2011-03-28 2015-05-10 Ново Нордиск А/С Новые аналоги глюкагона
KR101968344B1 (ko) * 2012-07-25 2019-04-12 한미약품 주식회사 옥신토모듈린 유도체를 포함하는 고지혈증 치료용 조성물

Also Published As

Publication number Publication date
HK1224303A1 (zh) 2017-08-18
KR20160077215A (ko) 2016-07-01
JP2017503782A (ja) 2017-02-02
TW201609129A (zh) 2016-03-16
AP2016009268A0 (en) 2016-06-30
IL245399A0 (en) 2016-06-30
CR20160223A (es) 2016-07-12
PH12016501184A1 (en) 2016-07-25
AU2014366427B2 (en) 2017-02-16
MX2016007984A (es) 2016-09-09
CA2928987A1 (en) 2015-06-25
US9688736B2 (en) 2017-06-27
WO2015094878A1 (en) 2015-06-25
TN2016000180A1 (en) 2017-10-06
EP3083669A1 (en) 2016-10-26
CN105793282A (zh) 2016-07-20
EA201691036A1 (ru) 2016-12-30
AU2014366427A1 (en) 2016-05-19
AR098616A1 (es) 2016-06-01
CL2016001473A1 (es) 2017-03-10
MA39108A1 (fr) 2017-11-30
SG11201604232TA (en) 2016-07-28
PE20160787A1 (es) 2016-08-17
BR112016012505A2 (pt) 2017-09-26
US20160311883A1 (en) 2016-10-27
NZ719451A (en) 2017-10-27
DOP2016000128A (es) 2016-06-30

Similar Documents

Publication Publication Date Title
MX372669B (es) Un compuesto que modifica el empalme del gen de foxm1 para usarse en la profilaxis o tratamiento de cáncer.
MX377534B (es) Compuestos para usarse en el tratamiento de hiperinsulinemia.
CU20160003A7 (es) Pirazololpiridinaminas sustituidas
IN2013DE00266A (es)
UY34575A (es) Composiciones y métodos para el tratamiento de diabetes y/u obesidad
AR097668A1 (es) Colorante-polímero
CR20160227A (es) Nuevo compuesto para el tratamiento de hipoglicemia severa
ECSP16024798A (es) Nuevo compuesto para el tratamiento de hipoglicemia severa
DOP2016000128A (es) Nuevo compuesto para el tratamiento de hipoglicemia severa
DOP2016000067A (es) Nuevo inhibidor de sglt1
BR112015021575A2 (pt) composição fungicida
CL2016000171A1 (es) Formulación de metaxalona.
IN2013MU03768A (es)
CY1119212T1 (el) Χρηση του odiparcil στη θεραπεια μιας μυκοπολυσακχαριδωσης
UA106373C2 (ru) Применение поллентара как средства фригопротекторного действия
CL2012000641S1 (es) Lavamanos.
TR201314933A2 (tr) Bakteriyel enfeksiyonların tedavisine yönelik bir kompozisyon.
TN2011000399A1 (fr) دراجة كهربائية ذات شحن الي
TN2011000372A1 (fr) جهاز مراقبة وتحكم في استهلاك المياه
UA72478U (ru) Применение полентара как средства фригопротекторного действия